Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CADL has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
CADL stock price ended at $5.33 on Friday, after rising4.31%
The Candel Therapeutics Inc stock price increased by 4.31% on the last trading day (16 May 2025), rising from 5.31 to 5.11. Throughout the last trading session, the stock experienced a fluctuation of 6.66% , ranging from a day low of $5.03 to a day high of 5.365. The price has declined in 5 of the last 10 days, resulting in a total change of 4.50% during this period. On the last day, trading volume decrease by -486.10K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 573.76K shares were traded, amounting to approximately 2.94M.
CADL Technical Signals
CADL(Candel Therapeutics Inc Corp) has 2 buy signals and 3 sell signals now. The current trend is downtrend starting from 2025-05-13. The total price change during this trend is -5.10%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of CADL over the last 5 trading days is 3.99M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
CADL Moving Average Analysis
Candel Therapeutics Inc's overall moving average trend leans more bullish as of Saturday, May 17, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $5.7437888, and $6.2219. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $4.1968112, and $3.7187. A break-down below any of these levels will issue sell signals.
CADL Short Selling Analysis
The short sale ratio of Candel Therapeutics Inc(CADL) as of 12 May 2025 is 25.50%, dropping from last trading day. With decreasing price from 4.81 to 5.01. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
3
Buy
2
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
2 Bullish Signals
2 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.115
Bullish
Momentum (10 days)
MOM_10 > 0
0.23
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.18
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
87.821
Bearish
Moving Average
Price crosses below 5-day SMA
--
Bearish
CADL Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Candel Therapeutics Inc(CADL), our algorithm predicts CADL's 1-month price at $4.36, with an -9.38%downwardshift. Using a similarity score up to 94.00%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Candel Therapeutics Inc (CADL.O) stock, as of Sunday, May 11, 2025 , forecasts a -9.38% change over the next month, based on its high correlation with SGML.O stock patterns. The similarity between their price movements over the analyzed periods is 94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
CADL
No Data
SGML
Down: -9.38%Similarity: 94%
Name
Similarity
Up/Down
SGML.O
94.00%
-9.38%
GDEN.O
92.41%
-2.07%
WPRT.O
91.31%
+3.26%
SWZ.N
90.83%
-7.24%
SPFI.O
90.47%
-5.30%
GFS.O
90.38%
-2.10%
CADL Seasonality Analysis
Based on CADL's historical stock price data across all years, the probability of a positive return in May is100.00%, suggesting it maybe an ideal month to invest in CADL. In contrast,Mayoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Candel Therapeutics Inc (CADL.O) stock in May has the highest probability of a positive return (100.00%), while June has the lowest probability (0.00%).
Performance Seasonality
The chart shows Candel Therapeutics Inc. (CADL)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Candel Therapeutics Inc (CADL.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CADL has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Candel Therapeutics Inc (CADL.O) stock in a year?
The radar chart shows that buying Candel Therapeutics Inc (CADL.O) stock in May has the highest probability of a positive return (100.00%), while June has the lowest probability (0.00%).
How has Candel Therapeutics Inc. (CADL)'s stock price performed over the past three years?
CADL's stock price fell by -16.95% in 2023,increased by 498.62% in 2024, and went down by 40.71% in 2025.
Is CADL a buy based on overall technical signals summary?
CADL has 2 buy signals and 3 sell signals now. Overall the technical rating for CADL is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of CADL.
What is the trend of Candel Therapeutics Inc (CADL)'s moving average?
Candel Therapeutics Inc's overall moving average trend leans more bullish as of May 17 2025, with 1 negative signals and 3 positive signal.
What is price prediction for CADL stock next month?
The price prediction chart for Candel Therapeutics Inc (CADL.O) stock, as of May 11 2025, forecasts a -9.38% change over the next month, based on its high correlation with SGML stock patterns. The similarity between their price movements over the analyzed periods is 94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for CADL Stock?
### **Price Prediction for CADL Stock in 2025**
Based on the analysis of technical indicators, recent news, and market sentiment, here is the price prediction for CADL stock:
1. **Price Prediction**: CADL stock is expected to reach **$15.00** by the end of 2025.
2. **Reason**: The stock is currently undervalued with a price of $5.055, and recent positive developments, such as the partnership with IDEA Pharma and promising trial results for CAN-2409, suggest strong growth potential. Additionally, the increasing interest from institutional investors and the $12B market cap target further support this bullish outlook.
What is price prediction 2030 for CADL Stock?
Candel Therapeutics (CADL) stock is predicted to reach **$15-$20 by 2030**, driven by the potential success of its lead asset CAN-2409 in treating various cancers. The stock's technical indicators, such as RSI and Stochastic Oscillator, suggest bullish potential, while the drug's promising trial results and partnerships position it for long-term growth.